Local Therapies for the Global COVID-19 Pandemic Blog Post
Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as a therapeutic option for COVID-19 patients.
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access? Blog Post
本次网络研讨会解析罕见病药物市场定价演变路径，并分享支持基于价值定价的最佳实践。
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs Blog Post
本次网络研讨会将详解 Certara 如何扩展其 PBPK Simcyp Simulator，新增 MPML MechDermA — 一种多相、多维的皮肤吸收模型。
Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development Blog Post
Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic neuralgia & fibromyalgia.
ICER’s Unsupported Drug Price Increase Report: An Analysis Blog Post
We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported Price Increases.”
Common Questions about Define-XML and the Stylesheet Blog Post
In this blog, we answer common questions about Define-XML and the Stylesheet, including all you need to know for study submission and what version to use.
Trends for Market Access, HEOR, and Real World Evidence Blog Post
This blog reviews trends for using health economics and outcomes research and real-world evidence to evaluate the value of medicines and health technologies.
